Biopharmaceutical research companies are conducting or have conducted more than 7,800 clinical trials of new medicines in collaboration with the state’s university medical schools, clinical research centers, and hospitals (1999 to present). 

Of the more than 7,800 clinical trials, 3,840 target the nation’s six most debilitating chronic diseases —asthma, cancer, diabetes, heart disease, mental illnesses and stroke.

“With such facilities as M.D. Anderson Cancer Center Orlando, the Cleveland Clinic Florida, the University of Miami and the University of Florida, it’s not at all surprising that biopharmaceutical research companies have taken advantage of the state’s strong biopharmaceutical and life sciences infrastructure to conduct nearly 8,000 clinical trials of new medicines in Florida since 1999, including 3,840 for the most debilitating chronic diseases—cancer, diabetes, heart disease, stroke, asthma and mental illnesses.” --Austin Curry, Executive Director, Elder Care Advocacy of Florida